Business & Finance
Vitrolife's net income up in Q3 2018
7 November 2018 -

Medical device company Vitrolife AB (STO:VITR) on Tuesday reported net income of SEK75m, or EPS of SEK0.69, for the third quarter of 2018, from July 2018 to September 2018.

This was an increase over net income of SEK65m, or EPS of SEK0.60, in Q3 2017.

Sales for the quarter amounted to SEK284m, up by 15% as compared with SEK246m in Q3 2017. Sales increased by 7% in local currency and consisted of organic growth.

Vitrolife develops, produces and markets medical devices for assisted reproduction.